MolecuLight

MolecuLight’s first commercial application, PRODIGI, is a handheld optical imaging device using patented fluorescence technology to instantly detect, analyze and quantify bacterial loads and other parameters objectively at point-of-care. More than 5 years of clinical trial validation shows PRODIGI enables significant improvement to the wound care industry. PRODIGI anables real-time swabbing/biopsies, image-guided wound debridement and quantitative monitoring of treatment response which results in improved patient outcomes and more efficient use of clinical resources. PRODIGI works with MolecuLight's next-generation proprietary disposable biological assays that will provide real-time diagnostic information about bacterial species ID, host/bacterial protease activity and other important biological parameters crucial for optimal diagnosis and treatment planning. Moleculight’s disruptive imaging technology platform has additional applications in other medical and non-medical markets.